Die Innovative Medicines Initiative 2 (IMI2) hat am 3. März 2020 die Ausschreibung einer Research and Innovation Action zum neuen Coronavirus (COVID-2019) geöffnet.

Topic

• Development of therapeutics and diagnostics combatting coronavirus infections

Scope: Considering that this is a newly-identified virus, the scope of this topic remains broad and must address at least one of the following objectives:

• development of antivirals as well as other types of therapeutics to address a rapid response to the current COVID-19 outbreak;
• development of therapeutics to address the current and/or future coronavirus outbreaks;
• development of diagnostics, ensuring rapid evaluation of candidates based on existing technologies;
• development of fast and reliable tools that go beyond the state of the art for detection of COVID-19 carriers and symptomatic individuals suspected of COVID-19 infection.

Preventive vaccines are specifically excluded from the scope of the Call.

Die IMI2 stellt ca. 45 Millionen Euro für diese Ausschreibung zur Verfügung. Die Ausschreibungsfrist endet am 31. März 2020.

Offizielle Website: https://www.imi.europa.eu/apply-funding/open-calls/imi2-call-21

Kontakt am EPC

© TU Dresden

Projektmanagerin / EPC-Kontakt MED

Name

Frau Beate Brenner

Horizon Europe (Vorhaben der MF)

E-Mail senden

Eine verschlüsselte E-Mail über das SecureMail-Portal versenden (nur für TUD-externe Personen).

Organisationsname

European Project Center

European Project Center

Adresse work

Besuchsadresse:

FAL Falkenbrunnen BT-A Würzburger Straße 35

01187 Dresden

Zeige Karte von diesem Ort.

work Tel.